Harrison, Stephen A. http://orcid.org/0000-0001-8285-2204
Manghi, Federico Perez
Smith, William B.
Alpenidze, Diana
Aizenberg, Diego
Klarenbeek, Naomi
Chen, Chi-Yi
Zuckerman, Eli
Ravussin, Eric http://orcid.org/0000-0003-2129-547X
Charatcharoenwitthaya, Phunchai
Cheng, Pin-Nan
Katchman, Helena
Klein, Samuel
Ben-Ari, Ziv
Mendonza, Anisha E.
Zhang, Yiming
Martic, Miljen http://orcid.org/0000-0002-0166-5421
Ma, Shenglin
Kao, Sheena
Tanner, Sandra
Pachori, Alok
Badman, Michael K.
He, YanLing
Ukomadu, Chinweike
Sicard, Eric
Funding for this research was provided by:
Novartis Pharmaceuticals
Article History
Received: 4 May 2021
Accepted: 6 May 2022
First Online: 20 June 2022
Competing interests
: S.A.H. reports advisory board fees, consultation and research grants from Akero, Altimmune, Axcella, CirU/Ls, Cymabay, Galectin, Genfit, Hepion, Hightide, Intercept, Madrigal, Metacrine, NGM and Northsea; consultation and research grants from CIVI, ENYO, Gilead, Novartis and Viking; also consultation for Canfite, Echosens, Foresite, Fortress, Kowa, Medpace, Prometic and Ridgeline. W.B.S. is an employee of Alliance for Multispecialty Research. S.K. reports advisory board fees and consultation work for Boehringer Ingelheim, Novo Nordisk and Merck, also grants and research support from Johnson & Johnson. E.R. reports funding from Novartis for the present study. E.S., F.P.M., D. Alpenidze, D. Aizenberg, N.K., C.Y.C., E.Z., P.C., P.N.C., H.K. and Z.B.A. have nothing to disclose. A.M., Y.Z., M.M., S.M., S.K., M.K.B. and Y.L.H. are employees of Novartis. A.P. and C.U. were employees of Novartis until August 2021 and February 2021, respectively. S.T. was an employee of Novartis until 2021.